Axsome Therapeutics, Inc. (AXSM)
148.79
-1.89
(-1.25%)
USD |
NASDAQ |
Dec 30, 16:00
151.00
+2.21
(+1.49%)
After-Hours: 07:16
Axsome Therapeutics Market Cap: 7.501B for Dec. 30, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Gilead Sciences, Inc. | 152.83B |
| ACADIA Pharmaceuticals, Inc. | 4.517B |
| Fortress Biotech, Inc. | 111.12M |
| TG Therapeutics, Inc. | 4.723B |
| Karyopharm Therapeutics, Inc. | 124.64M |
Market Cap Related Metrics
| PS Ratio | 13.05 |
| Price to Book Value | 101.74 |
| Price | 148.79 |
| Earnings Yield | -3.14% |